Capsulomics, Inc.
BiotechnologyMedical Diagnostics
Halethorpe, MD
About
Capsulomics, Inc., now known as Previse, is a pioneering medical diagnostics company dedicated to the early detection and prevention of esophageal cancer. The firm leverages cutting-edge molecular testing to empower gastroenterologists with critical insights into patient risk profiles for more informed treatment options.
Company Values
Capsulomics stands out by offering Esopredict, a unique molecular test developed from research at Johns Hopkins University, focusing specifically on personalized risk assessment for Barrett's esophagus patients.